Avadel Pharmaceuticals Call Volume Above Normal and Directionally Bullish

TipRanksSep 25 15:05 ET

Avadel Pharmaceuticals Announces Publication Of Data In 'Sleep Medicine' Highlighting Efficacy Of LUMRYZ Extended-Release Oral Suspension In Improving Narcolepsy Symptoms Regardless Of Concomitant Use Of An Alerting Agent

BenzingaSep 25 08:10 ET

Institutional Investors of Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Must Be Disappointed After Last Week's 3.9% Drop

Simply Wall StSep 18 11:08 ET

Avadel Pharmaceuticals Advances Pediatric Narcolepsy Treatment Review

TipRanksSep 12 07:28 ET

Express News | Avadel Pharmaceuticals PLC: Confirms Lumryz Snda Remains Under FDA Review

ReutersSep 12 07:05 ET

Express News | Avadel Pharmaceuticals Announces Publication of Restore Data Highlighting Challenges With Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly Lumryz™ Dosing (Sodium Oxybate) Extended-Release Oral Suspension (Ciii)

ReutersSep 3 08:00 ET